dpp4 and glp 1 together Mechanism of action for GIP, GLP-1 analogues inhibitors in Cellular Sites and Mechanisms Linking

Lower intake of iron-rich foods may gradually affect intake consistency, particularly when meals become smaller or less varied

They cannot be used to predict what will happen at microdose levels, where no comparable trial data exists

In brief, all of the mechanisms and actions that have protective efficiency on endothelium and VSMCs, can play a role in preventing vascular senescence (Figure 2)

They seem optimistic about continuing, but their use of the word just makes me wonder if this review reflects a placebo effect: Overall, results vary and support is inconsistent, especially considering the price

doi: 10.2337/dc24-S009 [DOI] [PMC free article] [PubMed] [Google Scholar] 14

The more cautious interpretation is that patients who receive GLP-1 receptor agonists may differ in important but incompletely measured ways from those treated with insulin or metformin, including overall health, treatment access, healthcare follow-up, or cardiometabolic care intensity